Logo image of KIN2.DE

KINROSS GOLD CORP (KIN2.DE) Stock Fundamental Analysis

FRA:KIN2 - Deutsche Boerse Ag - CA4969024047 - Common Stock - Currency: EUR

12.925  +0.19 (+1.49%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to KIN2. KIN2 was compared to 38 industry peers in the Metals & Mining industry. KIN2 gets an excellent profitability rating and is at the same time showing great financial health properties. KIN2 has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

KIN2 had positive earnings in the past year.
KIN2 had a positive operating cash flow in the past year.
Of the past 5 years KIN2 4 years were profitable.
Each year in the past 5 years KIN2 had a positive operating cash flow.
KIN2.DE Yearly Net Income VS EBIT VS OCF VS FCFKIN2.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

1.2 Ratios

The Return On Assets of KIN2 (8.73%) is better than 84.21% of its industry peers.
Looking at the Return On Equity, with a value of 13.83%, KIN2 belongs to the top of the industry, outperforming 81.58% of the companies in the same industry.
KIN2's Return On Invested Capital of 9.40% is amongst the best of the industry. KIN2 outperforms 81.58% of its industry peers.
The Average Return On Invested Capital over the past 3 years for KIN2 is in line with the industry average of 6.32%.
The 3 year average ROIC (6.23%) for KIN2 is below the current ROIC(9.40%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.73%
ROE 13.83%
ROIC 9.4%
ROA(3y)2.29%
ROA(5y)4.25%
ROE(3y)3.43%
ROE(5y)6.8%
ROIC(3y)6.23%
ROIC(5y)6.54%
KIN2.DE Yearly ROA, ROE, ROICKIN2.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

KIN2 has a Profit Margin of 18.43%. This is amongst the best in the industry. KIN2 outperforms 84.21% of its industry peers.
KIN2's Profit Margin has declined in the last couple of years.
KIN2's Operating Margin of 28.48% is amongst the best of the industry. KIN2 outperforms 89.47% of its industry peers.
KIN2's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 35.04%, KIN2 is in the better half of the industry, outperforming 63.16% of the companies in the same industry.
In the last couple of years the Gross Margin of KIN2 has grown nicely.
Industry RankSector Rank
OM 28.48%
PM (TTM) 18.43%
GM 35.04%
OM growth 3Y9.12%
OM growth 5Y8.75%
PM growth 3Y45.92%
PM growth 5Y-2.15%
GM growth 3Y3.98%
GM growth 5Y4.42%
KIN2.DE Yearly Profit, Operating, Gross MarginsKIN2.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

7

2. Health

2.1 Basic Checks

KIN2 has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
KIN2 has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, KIN2 has less shares outstanding
Compared to 1 year ago, KIN2 has an improved debt to assets ratio.
KIN2.DE Yearly Shares OutstandingKIN2.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
KIN2.DE Yearly Total Debt VS Total AssetsKIN2.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

KIN2 has an Altman-Z score of 2.69. This is not the best score and indicates that KIN2 is in the grey zone with still only limited risk for bankruptcy at the moment.
KIN2's Altman-Z score of 2.69 is fine compared to the rest of the industry. KIN2 outperforms 76.32% of its industry peers.
The Debt to FCF ratio of KIN2 is 1.05, which is an excellent value as it means it would take KIN2, only 1.05 years of fcf income to pay off all of its debts.
KIN2's Debt to FCF ratio of 1.05 is amongst the best of the industry. KIN2 outperforms 97.37% of its industry peers.
A Debt/Equity ratio of 0.18 indicates that KIN2 is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.18, KIN2 is doing good in the industry, outperforming 68.42% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 1.05
Altman-Z 2.69
ROIC/WACC1.07
WACC8.77%
KIN2.DE Yearly LT Debt VS Equity VS FCFKIN2.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 2.01 indicates that KIN2 has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.01, KIN2 is doing good in the industry, outperforming 76.32% of the companies in the same industry.
KIN2 has a Quick Ratio of 2.01. This is a bad value and indicates that KIN2 is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.83, KIN2 perfoms like the industry average, outperforming 44.74% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.01
Quick Ratio 0.83
KIN2.DE Yearly Current Assets VS Current LiabilitesKIN2.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

KIN2 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 54.20%, which is quite impressive.
KIN2 shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.87% yearly.
Looking at the last year, KIN2 shows a very strong growth in Revenue. The Revenue has grown by 21.44%.
KIN2 shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.04% yearly.
EPS 1Y (TTM)54.2%
EPS 3Y17.42%
EPS 5Y14.87%
EPS Q2Q%81.82%
Revenue 1Y (TTM)21.44%
Revenue growth 3Y11.35%
Revenue growth 5Y8.04%
Sales Q2Q%26.9%

3.2 Future

The Earnings Per Share is expected to decrease by -4.48% on average over the next years.
KIN2 is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -4.78% yearly.
EPS Next Y40.71%
EPS Next 2Y20.9%
EPS Next 3Y14.28%
EPS Next 5Y-4.48%
Revenue Next Year13.21%
Revenue Next 2Y6.6%
Revenue Next 3Y5.46%
Revenue Next 5Y-4.78%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
KIN2.DE Yearly Revenue VS EstimatesKIN2.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
KIN2.DE Yearly EPS VS EstimatesKIN2.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 0.4 0.6 0.8 1

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 21.54, the valuation of KIN2 can be described as rather expensive.
KIN2's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 27.75. KIN2 is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 15.36 indicates a correct valuation of KIN2.
KIN2's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of KIN2 to the average of the S&P500 Index (20.49), we can say KIN2 is valued slightly cheaper.
Industry RankSector Rank
PE 21.54
Fwd PE 15.36
KIN2.DE Price Earnings VS Forward Price EarningsKIN2.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

KIN2's Enterprise Value to EBITDA ratio is in line with the industry average.
84.21% of the companies in the same industry are more expensive than KIN2, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 13.19
EV/EBITDA 7.24
KIN2.DE Per share dataKIN2.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
KIN2 has an outstanding profitability rating, which may justify a higher PE ratio.
KIN2's earnings are expected to grow with 14.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.53
PEG (5Y)1.45
EPS Next 2Y20.9%
EPS Next 3Y14.28%

2

5. Dividend

5.1 Amount

KIN2 has a yearly dividend return of 0.80%, which is pretty low.
Compared to an average industry Dividend Yield of 3.75, KIN2 is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.44, KIN2's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.8%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
KIN2.DE Yearly Dividends per shareKIN2.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 0.05 0.1 0.15

5.3 Sustainability

15.55% of the earnings are spent on dividend by KIN2. This is a low number and sustainable payout ratio.
DP15.55%
EPS Next 2Y20.9%
EPS Next 3Y14.28%
KIN2.DE Yearly Income VS Free CF VS DividendKIN2.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B
KIN2.DE Dividend Payout.KIN2.DE Dividend Payout, showing the Payout Ratio.KIN2.DE Dividend Payout.PayoutRetained Earnings

KINROSS GOLD CORP

FRA:KIN2 (4/30/2025, 7:00:00 PM)

12.925

+0.19 (+1.49%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-12 2025-02-12/amc
Earnings (Next)05-06 2025-05-06
Inst Owners68.64%
Inst Owner ChangeN/A
Ins Owners0.21%
Ins Owner ChangeN/A
Market Cap15.90B
Analysts80
Price Target14.43 (11.64%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.8%
Yearly Dividend0.11
Dividend Growth(5Y)N/A
DP15.55%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.54%
Min EPS beat(2)-18.81%
Max EPS beat(2)25.89%
EPS beat(4)3
Avg EPS beat(4)16.49%
Min EPS beat(4)-18.81%
Max EPS beat(4)57.06%
EPS beat(8)7
Avg EPS beat(8)29.26%
EPS beat(12)8
Avg EPS beat(12)13.27%
EPS beat(16)10
Avg EPS beat(16)12.49%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)8.06%
PT rev (3m)16.41%
EPS NQ rev (1m)9.37%
EPS NQ rev (3m)5.71%
EPS NY rev (1m)17.53%
EPS NY rev (3m)11.63%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)4.98%
Revenue NY rev (3m)7.39%
Valuation
Industry RankSector Rank
PE 21.54
Fwd PE 15.36
P/S 3.51
P/FCF 13.19
P/OCF 7.39
P/B 2.64
P/tB 2.64
EV/EBITDA 7.24
EPS(TTM)0.6
EY4.64%
EPS(NY)0.84
Fwd EY6.51%
FCF(TTM)0.98
FCFY7.58%
OCF(TTM)1.75
OCFY13.53%
SpS3.68
BVpS4.9
TBVpS4.9
PEG (NY)0.53
PEG (5Y)1.45
Profitability
Industry RankSector Rank
ROA 8.73%
ROE 13.83%
ROCE 14.95%
ROIC 9.4%
ROICexc 10.02%
ROICexgc 10.02%
OM 28.48%
PM (TTM) 18.43%
GM 35.04%
FCFM 26.63%
ROA(3y)2.29%
ROA(5y)4.25%
ROE(3y)3.43%
ROE(5y)6.8%
ROIC(3y)6.23%
ROIC(5y)6.54%
ROICexc(3y)6.62%
ROICexc(5y)7.08%
ROICexgc(3y)6.62%
ROICexgc(5y)7.14%
ROCE(3y)9.92%
ROCE(5y)10.4%
ROICexcg growth 3Y20.62%
ROICexcg growth 5Y13.48%
ROICexc growth 3Y21.33%
ROICexc growth 5Y13.94%
OM growth 3Y9.12%
OM growth 5Y8.75%
PM growth 3Y45.92%
PM growth 5Y-2.15%
GM growth 3Y3.98%
GM growth 5Y4.42%
F-Score7
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 1.05
Debt/EBITDA 0.47
Cap/Depr 93.73%
Cap/Sales 20.89%
Interest Coverage 11.44
Cash Conversion 93.6%
Profit Quality 144.49%
Current Ratio 2.01
Quick Ratio 0.83
Altman-Z 2.69
F-Score7
WACC8.77%
ROIC/WACC1.07
Cap/Depr(3y)100.83%
Cap/Depr(5y)104.58%
Cap/Sales(3y)22.97%
Cap/Sales(5y)23.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.2%
EPS 3Y17.42%
EPS 5Y14.87%
EPS Q2Q%81.82%
EPS Next Y40.71%
EPS Next 2Y20.9%
EPS Next 3Y14.28%
EPS Next 5Y-4.48%
Revenue 1Y (TTM)21.44%
Revenue growth 3Y11.35%
Revenue growth 5Y8.04%
Sales Q2Q%26.9%
Revenue Next Year13.21%
Revenue Next 2Y6.6%
Revenue Next 3Y5.46%
Revenue Next 5Y-4.78%
EBIT growth 1Y74.49%
EBIT growth 3Y21.5%
EBIT growth 5Y17.5%
EBIT Next Year105.62%
EBIT Next 3Y25.1%
EBIT Next 5Y4.98%
FCF growth 1Y170.39%
FCF growth 3Y91.05%
FCF growth 5Y62.85%
OCF growth 1Y52.4%
OCF growth 3Y29.17%
OCF growth 5Y14.84%